Natural history of S13taphylococcus aureus nasal carriage and its relationship to exit-site infection

Peritoneal Dialysis International

Volumn 18, Issue 3, 1998, Pages 271-273

  Turner, Krys ^a   Uttley, Linda ^a   Scrimgeour, Ann ^a   McKewan, Ann ^a   Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Exit site infection; Staphylococcus aureus nasal carriage

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NOSE INFECTION; NOSE SMEAR; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION; COHORT ANALYSIS; INDWELLING CATHETER; INSTRUMENTATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; RISK FACTOR;

CATHETERS, INDWELLING; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0031596493     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Luzar MA, Coles CA, Faller B, Slingeneyer A, Daw G, Briar C, et al. Staphylococcus aureus nasal carriage and infection in patients on CAPD. N Engl J Med 1990; 322:505-9.
2. Piraino B, Perlmutter IA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl 2):S332-4.
3. Lye WC, Leong SO, Lee EJC. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993; 43:1357-62.
4. Twardowski Z, Prowant B. Staphylococcus aureus nasal carriage is not associated with an increased incidence of exit-site infection with the same organism. Perit Dial Int 1993; 13(Suppl 2):S306-9.
5. Doebbeling BN. Nasal and hand carriage of Staphylococcus aureus in health workers. J Chemother 1994; 6:11-17.
6. Yu VL, Goetz A, Wagner M, Smith PB, Rihs J, Henchett J, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:91-6.
7. Turner K, Gokal R, Uttley L, Scrimgeour A. Natural history of S. aureus nasal carriage and its relationship to exit-site infection. Perit Dial Int 1995; 15(4) (Suppl):S61.
8. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage: Exit-site infection and catheter loss in patients treated with CAPD. Perit Dial Int 1989; 9:61-4.
9. Sewell EM, Clarridge J, Lacke C, Weinman EJ, Young EJ. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982; 248:1493-5.
10. Bernardini J, Piraino B, Holley JL, Johnston JR, Lutes R. Randomized trial of prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampicin. Am J Kidney Dis 1996; 27:695-700.
11. Coles GA for the Mupirocin Study Group. The effect of intranasal mupirocin on CAPD exit site infections. J Am Soc Nephrol 1994; 5:439.
12. Pérez-Fontán M, García-Falcón J, Rosales M, Rodriguez-Carmona A, Adeva M, Rodriguez-Lozano I, et al. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin: long term results. Am J Kidney Dis 1993; 22:708-12.
13. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, et al. Randomized controlled trial of prophylactic rifampicin for peritoneal dialysis related infections. Am J Kidney Dis 1991; 18:225-31.